Výsledky vyhledávání - "Erwin, Schollmayer"

Pharmacokinetics of rotigotine transdermal system in adolescents with idiopathic restless legs syndrome (Willis–Ekbom disease)

Autor: Erwin Schollmayer, John D. Hudson, Jan-Peer Elshoff, Daniel L. Picchietti, Francisco Ramirez, Kimberly Doggett, Kimberly Moran, Arthur S. Walters, Keith Ridel, M. Oortgiesen

Publikováno v: Sleep Medicine. 32:48-55

Objective To investigate the pharmacokinetics (PK) of rotigotine transdermal system in adolescents with moderate-to-severe idiopathic restless legs syndrome (RLS). Methods This multicenter, open-label, dose-escalation study enrolled patients ≥13 to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f0deb1f0a5eaf923f108399dfd33ad
https://doi.org/10.1016/j.sleep.2016.04.012

Zobrazit plný text záznamu

Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study

Autor: Erwin Schollmayer, Daniela Kelling, Michael Lang, Heike Benes, Reinhard Berkels, Hanna Schroeder, Monica Canelo, Claudia Trenkwalder, Tanja Heidbrede

Publikováno v: Sleep Medicine. 30:257-265

Aim The aim of this study is to assess the effect of switching to rotigotine transdermal patch on severity of restless legs syndrome (RLS) in patients who experienced acute augmentation with previous oral dopaminergics. Methods In this 13-month obser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0bcc24cb0785304f44b61f3f7692800
https://doi.org/10.1016/j.sleep.2015.10.006

Zobrazit plný text záznamu

Significant association between systolic and diastolic blood pressure elevations and periodic limb movements in patients with idiopathic restless legs syndrome

Autor: Frank Grieger, Karl Kesper, Axel Bauer, Claudia Trenkwalder, Lars Joeres, Werner Cassel, Erwin Schollmayer

Publikováno v: Sleep Medicine. 17:109-120

Objective A new and unique methodology was developed to evaluate the association between periodic limb movements (PLMs) and nocturnal blood pressure (BP) excursions in patients with restless legs syndrome (RLS). Methods All data were collected at bas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489a74eeb2487e00e93b97eae1e950e4
https://doi.org/10.1016/j.sleep.2014.12.019

Zobrazit plný text záznamu

Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire

Autor: Frank Grieger, Kimberly Moran, Arthur S. Walters, Heike Benes, Wolfgang H. Oertel, Ralf Kohnen, Richard P. Allen, Erwin Schollmayer

Publikováno v: Sleep Medicine. 14:1375-1380

Background The SP790 study (ClinicalTrials.gov, NCT00136045 ) showed benefits of rotigotine over placebo in improving symptom severity of restless legs syndrome (RLS), also known as Willis-Ekbom disease, on the International Restless Legs Syndrome St

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd4cea2b5f26f2bc01a9718fe714938
https://doi.org/10.1016/j.sleep.2013.09.008

Zobrazit plný text záznamu

Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany

Autor: Cornelius G. Bachmann, Reinhard Berkels, Daniela Berg, Thomas Lauterbach, Karin Stiasny-Kolster, Frank Grieger, Werner Hofmann, Erwin Schollmayer

Publikováno v: Sleep Medicine. 14:475-481

Objective We aimed to assess effectiveness and tolerability of rotigotine in patients with moderate to severe idiopathic restless legs syndrome (RLS) under daily practice conditions in Germany. Methods In this 3-month noninterventional study, effecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f04c8afa474a378a6b9014a838c9aa
https://doi.org/10.1016/j.sleep.2013.02.013

Zobrazit plný text záznamu

Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial

Autor: Erwin Schollmayer, Heike Benes, Yves Dauvilliers, Virpi Rauta, Elisabeth Dohin, Markku Partinen, John W. Winkelman, Nadine Goldammer, Hanna Schröder, Daniel Rifkin

Publikováno v: American Journal of Kidney Diseases
American Journal of Kidney Diseases, Elsevier, 2016, 68 (3), pp.434-443. ⟨10.1053/j.ajkd.2015.12.027⟩

Background Restless legs syndrome (RLS) has been associated with insomnia, decreased quality of life, and increased morbidity and mortality in end-stage renal disease. This randomized controlled trial investigated effects of rotigotine in patients wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe92a74f123e13746a027423b5dadce
https://hal.umontpellier.fr/hal-01880785

Zobrazit plný text záznamu

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine

Autor: Diego Garcia-Borreguero, Erwin Schollmayer, Luigi Ferini-Strambi, Heike Benes, Ralf Kohnen, Andreas Fichtner

Publikováno v: Sleep Medicine. 13:589-597

Objective To assess the risk of augmentation under treatment with the transdermally delivered dopamine agonist rotigotine for restless legs syndrome (RLS). Methods Experts in RLS augmentation retrospectively reviewed data from two double-blind, place

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86cd4443e6c596b115bbcd9d7613c887
https://doi.org/10.1016/j.sleep.2011.09.016

Zobrazit plný text záznamu

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

Autor: June M. Fry, Richard P. Allen, William G. Ondo, David B. Kudrow, John W. Winkelman, Philip M. Becker, Wayne A. Hening, Andreas Fichtner, Arthur S. Walters, Richard K. Bogan, Kurt W. Lesh, Erwin Schollmayer

Publikováno v: Movement Disorders. 25:1675-1683

This randomized, double-blinded, placebo-controlled trial (NCT00135993) assessed efficacy and safety of the dopamine agonist rotigotine in the treatment of idiopathic restless legs syndrome (RLS) over a 6-month maintenance period. A total of 505 elig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::243eb50d174b30761a7d742c2feb9daa
https://doi.org/10.1002/mds.23157

Zobrazit plný text záznamu

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

Autor: Wolfgang H, Oertel, Heike, Benes, Diego, Garcia-Borreguero, Peter, Geisler, Birgit, Högl, Claudia, Trenkwalder, Ingrid, Tacken, Erwin, Schollmayer, Ralf, Kohnen, Karin, Stiasny-Kolster, F, Puertas

Publikováno v: Sleep Medicine. 9:865-873

Long-term efficacy and tolerability data are not yet available for patch formulations of dopamine agonists in restless legs syndrome.Efficacy and safety of rotigotine (0.5-4mg/24h), formulated as a once-daily transdermal system (patch), were investig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb91f52579abf9acb3ad1453269c6a3f
https://doi.org/10.1016/j.sleep.2008.04.012

Zobrazit plný text záznamu

Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe

Autor: Wolfgang H, Oertel, Heike, Benes, Diego, Garcia-Borreguero, Peter, Geisler, Birgit, Högl, Bernd, Saletu, Claudia, Trenkwalder, Kenneth W, Sommerville, Erwin, Schollmayer, Ralf, Kohnen, Karin, Stiasny-Kolster, F, Puertas

Publikováno v: Sleep Medicine. 9:228-239

In a pilot placebo-controlled study, low dosages of 0.5-2mg/24h rotigotine showed a dose-dependent beneficial effect in restless legs syndrome (RLS) patients.Efficacy and safety of the dopamine agonist rotigotine, formulated as a once-daily transderm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3177211fac0b4b497310cbd89383e732
https://doi.org/10.1016/j.sleep.2007.04.010

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání